Status: current, Defined. Date: 31-Jul 2020. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3897109015 | Enfortumab vedotin only product in parenteral dose form | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3897110013 | Product containing only enfortumab vedotin in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Enfortumab vedotin only product in parenteral dose form | Has manufactured dose form | Parenteral dose form | true | Inferred relationship | Some | ||
| Enfortumab vedotin only product in parenteral dose form | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some | ||
| Enfortumab vedotin only product in parenteral dose form | Is a | Enfortumab vedotin-containing product in parenteral dose form | true | Inferred relationship | Some | ||
| Enfortumab vedotin only product in parenteral dose form | Count of base of active ingredient | 1 | false | Inferred relationship | Some | ||
| Enfortumab vedotin only product in parenteral dose form | Has active ingredient | Enfortumab vedotin | true | Inferred relationship | Some | 1 | |
| Enfortumab vedotin only product in parenteral dose form | Is a | Enfortumab vedotin only product | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR